48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohortAlfonso Cabello, Miguel Górgolas, Juan Carlos López Bernardo de Quirós et al.|PLoS ONE|2022Cited by 20
Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015José Antonio Iribarren, Miguel Ángel von Wichmann, Rafael Rubio et al.|Enfermedades Infecciosas y Microbiología Clínica|2016Cited by 18
A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral loadJA Arranz Caso, Miguel Górgolas, JC López et al.|HIV Medicine|2005Cited by 14
Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)José A. Pérez‐Molina, Estebán Martínez, Rosa Polo et al.|Enfermedades Infecciosas y Microbiología Clínica|2018Cited by 12
Documento de consenso sobre el manejo de la patología renal en pacientes con infección por VIHJosé Luis Górriz, José M. Miró, Félix Gutiérrez et al.|Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)|2014Cited by 11